Preclinical Laboratory Research Services

The contract titled Preclinical Laboratory Research Services seeks to engage a contractor in conducting in vitro and in vivo studies to validate therapeutic targets, evaluate drug candidates, and support the development of medical devices. This work encompasses the design and execution of assays, establishment of animal models, and comprehensive toxicity screening, all performed in accordance with Good Laboratory Practice (GLP) standards to ensure data integrity and regulatory compliance. The scope requires technical expertise in preclinical research methodologies and adherence to rigorous scientific protocols suitable for defense and medical applications. The contract is issued as a subcontract by the Department of the Army through the U.S. Army Medical Research and Applications Agency under the NAICS code 541710. It was posted on June 17, 2026, with a response deadline of November 4, 2026. There is no specified set-aside type or organizational restriction, and the place of performance and point of contact details are not provided. Interested parties must submit their proposals before the deadline to be considered for engagement in critical preclinical research supporting military and public health initiatives.